Boundless Bio, Inc. (BOLD)
2.63
+0.01
(+0.38%)
USD |
NASDAQ |
Oct 05, 12:21
Boundless Bio Market Cap : 59.11M for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 58.88M |
| October 01, 2026 | 58.21M |
| September 30, 2026 | 56.41M |
| September 29, 2026 | 57.54M |
| September 28, 2026 | 58.66M |
| September 25, 2026 | 59.78M |
| September 24, 2026 | 58.44M |
| September 23, 2026 | 60.68M |
| September 22, 2026 | 64.73M |
| September 21, 2026 | 63.60M |
| September 18, 2026 | 63.15M |
| September 17, 2026 | 62.93M |
| September 16, 2026 | 63.38M |
| September 15, 2026 | 63.15M |
| September 14, 2026 | 63.83M |
| September 11, 2026 | 63.60M |
| September 10, 2026 | 63.83M |
| September 09, 2026 | 64.05M |
| September 08, 2026 | 64.28M |
| September 04, 2026 | 64.50M |
| September 03, 2026 | 64.50M |
| September 02, 2026 | 64.95M |
| September 01, 2026 | 64.95M |
| August 31, 2026 | 63.15M |
| August 28, 2026 | 63.60M |
| Date | Value |
|---|---|
| August 27, 2026 | 64.28M |
| August 26, 2026 | 65.51M |
| August 25, 2026 | 66.08M |
| August 24, 2026 | 66.53M |
| August 21, 2026 | 67.42M |
| August 20, 2026 | 65.18M |
| August 19, 2026 | 64.28M |
| August 18, 2026 | 64.28M |
| August 17, 2026 | 63.60M |
| August 14, 2026 | 63.60M |
| August 13, 2026 | 62.37M |
| August 12, 2026 | 62.48M |
| August 11, 2026 | 61.81M |
| August 10, 2026 | 63.38M |
| August 07, 2026 | 64.95M |
| August 06, 2026 | 63.83M |
| August 05, 2026 | 62.93M |
| August 04, 2026 | 60.79M |
| August 03, 2026 | 57.59M |
| July 31, 2026 | 56.02M |
| July 30, 2026 | 56.02M |
| July 29, 2026 | 55.57M |
| July 28, 2026 | 55.35M |
| July 27, 2026 | 55.57M |
| July 24, 2026 | 57.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.386B |
| Alnylam Pharmaceuticals, Inc. | 29.00B |
| Savara, Inc. | 981.81M |
| Vericel Corp. | 2.067B |
| Biogen, Inc. | 32.37B |
Market Cap Related Metrics
| Price to Book Value | 0.8959 |
| Price | 2.63 |
| Earnings Yield | -108.6% |